Search
Search Results
##search.searchResults.foundPlural##
-
IRON DEFICIENCY ANAEMIA AMONG PRE-SCHOOL CHILDREN WITH SICKLE CELL ANAEMIA: STILL A RARE DIAGNOSIS?
1285PDF: 808HTML: 2892cover leer: 136 -
-
AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging
184PDF: 131Suppl. Files: 26HTML: 5 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
1997PDF: 774HTML: 1009 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2388PDF: 900HTML: 500 -
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2481PDF: 929HTML: 2220 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1787PDF: 814HTML: 1562 -
Major Artery Occlusion: a Rare Complication of Sickle Cell Disease
1332PDF: 1020HTML: 4594 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3191PDF: 1690HTML: 1075 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1374PDF: 911HTML: 304 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
801PDF: 528HTML: 4006 -
-
CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease
2103PDF: 1391HTML: 685 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2537PDF: 783HTML: 5192 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1278PDF: 789HTML: 120 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2209PDF: 845HTML: 2078 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1463PDF: 523HTML: 684 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1546PDF: 830HTML: 1025Picture 1: 156 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
938PDF: 598Html: 149 -
Correlation to FVIII:C in two thrombin generation tests: TGA-CAT and INNOVANCE ETP
2195PDF: 760HTML: 848Figure 2: 204Figure 1: 156 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1230PDF: 517HTML: 23017 -
PREVALENCE OF ß-THALASSEMIA MUTATIONS AMONG NORTHEASTERN IRANIAN POPULATION AND THEIR IMPACTS ON HEMATOLOGICAL INDICES AND APPLICATION OF PRENATAL DIAGNOSIS, A SEVEN-YEARS STUDY
2350PDF: 914HTML: 368Supplementary table 1: 205Some of the mutation detection samples: 195 -
PREVALENCE OF ALPHA THALASSEMIA IN MICROCYTIC ANEMIA: A TERTIARY CARE EXPERIENCE FROM NORTH INDIA
2368PDF: 1209HTML: 4661table: 193fig 1: 202fig 2: 160 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4174PDF: 1497HTML: 436 -
COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon
798PDF: 795HTML: 107 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2174PDF: 919HTML: 286 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1199PDF: 950HTML: 194 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1547PDF: 857HTML: 3146Figure 5: 148Figure 4: 149Figure 3: 182Figure 1: 161Figure 2: 155







